Quoin Pharmaceuticals QNRX
NASDAQ QNRX
$4.01 -0.10 (-2.43%)
As of: Oct 22, 2026 · 2:36 PM EDT

Quoin Pharmaceuticals (QNRX) Cash from Financing Activities (2021 - 2026)

Updated

Quoin Pharmaceuticals (QNRX) posted Cash from Financing Activities of -$151,947 for the quarter ended Jun 30, 2026, compared with -$150,000 a year earlier.

Analysis

Quoin Pharmaceuticals (QNRX) Cash from Financing Activities (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Quoin Pharmaceuticals was $18.05 million, up 219.7% year-over-year; for the year ended Dec 31, 2025, it was $18.01 million, up 64.2% from the prior year.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of 58.7% (years ended Dec 2020 to Dec 2025).
  • In prior years, Quoin Pharmaceuticals' Cash from Financing Activities was $10.97 million in the year ended Dec 31, 2024 (+110.2%), $5.22 million in the year ended Dec 31, 2023 (-62.8%), $14.01 million in the year ended Dec 31, 2022 (+3.7%) and $13.5 million in the year ended Dec 31, 2021 (+655.5%).
  • The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Cash from Financing Activities since the quarter ended Dec 31, 2023.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $55,982 (quarter ended Mar 31, 2026), $18.29 million (quarter ended Dec 31, 2025) and -$150,000 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -8.53 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -5.05 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -3.89 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 2.34 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -3.66 Bn
10 Quoin Pharmaceuticals 324,571.14 -45.14 Mn - -151,947.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -151,947.00
Mar 31, 2026 55,982.00
Dec 31, 2025 18.29 Mn
Sep 30, 2025 -150,000.00
Jun 30, 2025 -150,000.00
Mar 31, 2025 22,958.00
Dec 31, 2024 5.92 Mn
Sep 30, 2024 -149,892.00
Jun 30, 2024 -136,275.00
Mar 31, 2024 5.33 Mn
Dec 31, 2023 -182,583.00
Sep 30, 2023 -275,000.00
Jun 30, 2023 -75,000.00
Mar 31, 2023 5.75 Mn
Dec 31, 2022 -446,862.00
Sep 30, 2022 14.75 Mn
Jun 30, 2022 -150,000.00
Mar 31, 2022 -150,000.00
Dec 31, 2021 10.26 Mn
Sep 30, 2021 -52,770.00
API Access

Quoin Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=QNRX&period=max&api_key=YOUR_API_KEY